Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

Virus-like particles (VLPs) have gained increasing interest for their use as vaccines due to their repetitive antigenic structure that is capable of efficiently activating the immune system. The efficacy of VLP immunization may lie in its ability to traffic into draining lymph nodes while activating antigen-presenting cells to initiate the orchestration of signals required for the development of a robust immune response. Currently, there is no comprehensive study showing the correlation of different VLP vaccination routes to immune outcome. In this study, we took an optical imaging approach to directly visualize the trafficking of simian-human immunodeficiency (SHIV) VLPs after immunization by commonly used routes and analyzed the corresponding humoral and cellular immune responses generated. We found that VLPs can easily enter the subcapsular sinus of draining lymph nodes with quantitative differences in the number of lymph node involvement depending on the immunization route used. Intradermal immunization led to the largest level of lymph node involvement for the longest period of time, which correlated with the strongest humoral and cellular immune responses. Flow cytometry analysis from extracted splenocytes showed that intradermal immunization led to the largest population of germinal center and activated B cells, which translated into higher antibody levels and antigen-specific cytotoxic T lymphocyte responses. Our results indicate that VLPs traffic into lymph nodes upon immunization and can be directly visualized by optical imaging techniques. Intradermal immunization showed improved responses and might be a preferable delivery route to use for viral and cancer immunotherapeutic studies involving VLPs.

[1]  T. Phan,et al.  Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells , 2007, Nature Immunology.

[2]  M. Skobe,et al.  Structure, function, and molecular control of the skin lymphatic system. , 2000, The journal of investigative dermatology. Symposium proceedings.

[3]  A. Farr,et al.  The structure of the sinus wall of the lymph node relative to its endocytic properties and transmural cell passage. , 1980, The American journal of anatomy.

[4]  C. Leclerc,et al.  Virus-like particles: a new family of delivery systems , 2002, Expert review of vaccines.

[5]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[6]  Eva M. Sevick-Muraca,et al.  Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer , 2007, Journal of Nuclear Medicine.

[7]  Katrin Schwarz,et al.  Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.

[8]  J. Heeney,et al.  Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. , 1998, Virology.

[9]  G. Nossal,et al.  FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jicheng Li,et al.  Ultrastructure and three‐dimensional study of the lymphatic stomata in the costal pleura of the rabbit , 2003, Microscopy research and technique.

[11]  M. Jenkins,et al.  The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. , 2007, Immunity.

[12]  Martin Müller,et al.  Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. , 2007, Virology.

[13]  R. Compans,et al.  Production and characterization of simian--human immunodeficiency virus-like particles. , 2000, AIDS research and human retroviruses.

[14]  Q. Yao,et al.  SHIV virus-like particles bind and activate human dendritic cells. , 2004, Vaccine.

[15]  Stephen W. Martin,et al.  Regulation of Memory Antibody Levels: The Role of Persisting Antigen versus Plasma Cell Life Span , 2007, The Journal of Immunology.

[16]  S. L. Clark The reticulum of lymph nodes in mice studied with the electron microscope. , 1962, The American journal of anatomy.

[17]  B. Zheng,et al.  Germinal Center Helper T Cells Are Dual Functional Regulatory Cells with Suppressive Activity to Conventional CD4+ T Cells , 2007, The Journal of Immunology.

[18]  A. Kingsman,et al.  Induction of single and dual cytotoxic T‐lymphocyte responses to viral proteins in mice using recombinant hybrid Ty–virus‐like particles , 1996, Immunology.

[19]  C. Wheeler,et al.  Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. , 2006, Vaccine.

[20]  G. Azzali,et al.  The lymphatic vessels and the so-called "lymphatic stomata" of the diaphragm: a morphologic ultrastructural and three-dimensional study. , 1999, Microvascular research.

[21]  E. Ingulli,et al.  Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.

[22]  G. László,et al.  Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells. , 2001, Immunology letters.

[23]  R. Phipps,et al.  The Maintenance and Regulation of the Humoral Immune Response: Persisting Antigen and the Role of Follicular Antigen‐Binding Dendritic Cells as Accessory Cells , 1980, Immunological reviews.

[24]  E. Kohli,et al.  Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response , 2001, Journal of Virology.